Dexamethasone Metasulfobenzoate Sodium

Name: Dexamethasone Metasulfobenzoate Sodium

CAS: 3936-02-5

Feature:

Dexamethasone Metasulfobenzoate Sodium is a sulfonatobenzoate. It derives from a dexamethasone. Dexamethasone Metasulfobenzoate Sodium is an ophthalmic and auricular corticosteroid used with antibiotics for the treatment of otitis externa, blepharitis, and other inflammatory eye conditions. Dexamethasone Metasulfobenzoate Sodium is one of the commonly used drugs in clinical practice. It is often used in combination with other drugs in clinical practice, and it has anti-inflammatory, anti-toxic and anti-allergic effects. It is a synthetic adrenocortical hormone. Dexamethasone Metasulfobenzoate Sodium belongs to the class of glucocorticoids. Glucocorticoids can promote the metabolism of the three major nutrients, and at the same time can prevent protein synthesis. Long-term external use can lead to more serious consequences, but the adverse reactions are much smaller than oral medication.

Dexamethasone Metasulfobenzoate Sodium has a pronounced dose-dependent effect on the metabolism of carbohydrates, proteins and fats. With systemic use of therapeutic activity of dexamethasone is due to anti-inflammatory, antiallergic, immunosuppressive and antiproliferative action.

For external and local use of therapeutic activity of dexamethasone is due to anti-inflammatory, antiallergic and antiexudative effect. This medication Inhibits the function of leukocytes and tissue macrophages. Dexamethasone restricts the migration of leukocytes in the area of inflammation.

Dexamethasone Metasulfobenzoate Sodium has the following applications/functions:

1. With direct application to the vessels dexamethasone metasulfobenzoate sodium has a vasoconstrictor effect.

2. This drug violates the ability of macrophages to phagocytosis and the formation of interleukin-1. Dexamethasone Metasulfobenzoate Sodium decreases capillary permeability caused by histamine release. This medicine inhibits the activity of fibroblasts and collagen formation.

3. In high doses dexamethasone metasulfobenzoate sodium may increase the excitability of brain tissue and contributes to lowering the threshold of convulsive readiness.

4. When dexamethasone metasulfobenzoate sodium applied topically in ophthalmology it absorbed through the cornea with intact epithelium in moisture anterior chamber. When inflammation of the tissues of the eye or mucosal damage and corneal absorption rate of dexamethasone significantly increased.

Composition: 

Appearance: White powder

Packing: 25kg/drum or as discussed

Shelf Life: 2 years

Storage: Store in cool and dry area

Certification:ISO GMP KOSHER HALAL